HONORS AND AWARDS
2000
Honors in Internal Medicine
2000
Honors in Obstetrics & Gynecology
2000
Winner of Indian Academy of Pediatrics Quiz
2000
Dr. B.R.Damle Award in Medicine
1999
Dr. Phadkes Award in Pharmacology
1997
Honors in Biochemistry
RESEARCH (Principal Investigator Responsibilities)
NCT: N/A
Prospective Observational Study of Mobile App-Based Patient-Reported Outcomes in Advanced Breast Cancer, Phase: N/A, Non-interventional
NCT: N/A
Palbociclib in Hormone Receptor Positive Advanced Breast Cancer: A Prospective Multicenter Non-Interventional Study, Phase: N/A, Non-interventional
NCT02743494
A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects with Resected Esophageal, or Gastroesophageal Junction Cancer, Phase: III, Interventional
NCT02582879
informCLL™: A Disease Registry for Patients with Chronic Lymphocytic Leukemia, Phase: IV, Non-interventional
NCT03001882
An Exploratory Study of the Biologic Effects and Biomarkers of Nivolumab in Combination with Ipilimumab in Subjects with Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC), Phase: II, Interventional
NCT02869789
A Phase 3b/4 Safety Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Non-Small Cell Lung Cancer, Phase: III / IV, Interventional
NCT03036098
A Phase 3, Open-label, Randomized Study of Nivolumab Combined with Ipilimumab, or with Standard of Care Chemotherapy, Versus Standard of Care Chemotherapy in Participants with Previously Untreated Unresectable or Metastatic Urothelial Cancer, Phase: III, Interventional
NCT01358877
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants with Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer (APHINITY), Phase: III, Interventional
NCT01945775
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients with BRCA Mutation (EMBRACA Study), Phase: III, Interventional
NCT02252159
Prospective Observational Study of Patients with Polycythemia Vera in US Clinical Practices (REVEAL) Phase: IV, Non-interventional
NCT02008227
A Study of Atezolizumab Compared With Docetaxel in Participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy (OAK), Phase: III, Interventional
NCT02125461
A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients with Stage III Unresectable Non-Small Cell Lung Cancer (PACIFIC), Phase: III, Interventional
NCT02366143
A Study of Atezolizumab in Combination with Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants with Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower150), Phase: III, Interventional
NCT: N/A
Lung Cancer Molecular Profiling and Clinical Outcomes in US Community Oncology Practices, Phase: IV, Non-interventional
NCT03029780
An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma (CheckMate 800), Phase: II, Interventional
NCT01615068
An Observational Study in Patients with HER2 Positive Metastatic Breast Cancer (SystHERs Registry), Phase: IV, Non-interventional
NCT01745367
Tivozanib Hydrochloride in Combination with Paclitaxel Versus Placebo with Paclitaxel in Patients with Locally Recurrent or Metastatic Triple Negative Breast Cancer (BATON-BC), Phase: II, interventional
NCT01593228
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial, Phase: N/A, Interventional
NCT01369433
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols, Phase: N/A, Interventional
PUBLICATIONS
NCODA's Positive Quality Intervention in Action
"PQI in Action: ADCETRIS"
Oncolytics Today
"Coordinating Combination Regimens: A Primer on an Emerging Trend in Oncology"
Lung Cancer Journal
"Luminespib Plus Pemetrexed in Patients with Non-Squamous Non-Small Cell Lung Cancer"
Annals of Oncology, Volume 29
“A phase II exploratory study of biomarkers associated with the efficacy of first-line nivolumab (nivo) plus ipilimumab (ipi) in patients (pts) with stage IV or recurrent NSCLC.”
ESMO 2019 Abstract
“Measures of functional status in adults aged ≥ 70 years with advanced breast cancer (ABC) receiving palbociclib (PAL) combination therapy in POLARIS.”
San Antonio Breast Cancer Symposium
“Quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer treated with palbociclib in real-world practice settings.”
Lung Cancer
“Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer.”
Young Women with Neutropenia. Vol. 46 No.13
Consultant
Infections in Medicine. Vol.26 no.2.
“Emphysematous Pyelonephritis Caused by Pasteurella Multocida After Embolization for Renal Cell Cancer.”
Japanese Society of Medical Oncology
"CheckMate 592: A Phase 2 Exploratory Study of Biomarkers of Efficacy for 1L Nivolumab + Ipilimumab in Advanced NSCLC"